NIA
SRPT icon

NIA Impact Advisors’s Sarepta Therapeutics SRPT Stock Holding History

NIA Impact Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,662
Closed -$246K – 58
2021
Q3 		$246K Sell
2,662
-10,163
-79% -$783K 0.1% 57
2021
Q2 		$997K Buy
12,825
+502
+4% +$38.1K 0.49% 45
2021
Q1 		$918K Buy
12,323
+2,599
+27% +$240K 0.5% 45
2020
Q4 		$1.64M Buy
+9,724
New +$1.44M 0.86% 42

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

NIA Impact Advisors's SRPT Position: Q4 2021 in Review

NIA Impact Advisors sold out of Sarepta Therapeutics (SRPT) in Q4 2021, closing a stake of 2,662 shares — an estimated $246K sold.

NIA Impact Advisors first reported a position in SRPT in Q4 2020 and held it in 4 quarters. The position peaked at $1.64M in Q4 2020. 343 funds tracked by Wall St. Rank hold SRPT as of Q4 2021.

  • NIA Impact Advisors reported no remaining Sarepta Therapeutics position as of Q4 2021 after selling out during the quarter.
  • NIA Impact Advisors sold 2,662 Sarepta Therapeutics shares in Q4 2021, an estimated $246K.
  • NIA Impact Advisors first reported a position in Sarepta Therapeutics in Q4 2020 and held it in 4 quarters.
  • NIA Impact Advisors's Sarepta Therapeutics position peaked at $1.64M in Q4 2020.
  • 343 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2021.

Based on NIA Impact Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.